Key result
This symposium introduction highlights the need for a greater understanding of interstitial fluid physiology to improve the design and success of implantable glucose monitors.
This symposium introduction highlights the need for a better understanding of interstitial fluid physiology to improve implantable glucose monitoring technologies.
Nearly all commercially available glucose sensors share the subcutaneous interstitial fluid (ISF) compartment as their preferred implantation site. However, ISF physiology as it relates to glucose sensors is not well understood. This special symposium titled "Interstitial Fluid Physiology as It Relates to Glucose Monitoring Technologies" is intended to help to bridge the gap in our understanding. This symposium is intended to foster a greater understanding of biological factors that impact the success of implantable glucose monitors and to inspire additional research in the area of ISF physiology as it relates to glucose sensing. Recognition that sensor designers need to have an intimate understanding of the biological environment in which their sensor will reside is emphasized. The symposium is published in two parts, with part I published in September 2010 and part II published in May 2011. All articles published in this symposium are summarized herein.
No takes yet. Share an insight, caveat, or question.
Wisniewski et al. (2011) conducted an editorial in Glucose monitoring. This symposium introduction highlights the need for a greater understanding of interstitial fluid physiology to improve the design and success of implantable glucose monitors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: